Introduction to Oncology Course is back for 2018

Yesterday we held the first Introduction to Oncology course of 2018 at the Royal Marsden Hospital in central London. It was a great success! The day included discussing pharmaceutical care planning for the cancer patient with Kelly Baillie and delving into the the world of targeted therapies with Emma Foreman; we had a fantastic interactive session from Bruce Burnett on oncological emergencies and great presentations on radiotherapy and administration of SACT from Alex Britton and Claudia Baptista. If you weren’t lucky enough to attend don’t worry…we filmed the whole thing! The E&T team will now be working hard to use the footage to create a digital version of the course that will be hosted on the BOPA website, so even more members can access this fantastic resource. Watch this space!!

Latest News

By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article
By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article
By BOPA Executive Committee on 30th October 2026

Acute and Supportive Oncology Clinical Consensus Statement

BOPA welcomes the Acute and Supportive Oncology Clinical Consensus Statement, to which we were pleased to contribute. It will be a benchmark for the sector, bringing direction and consistency as…

Read article